ClinicalTrials.Veeva

Menu

Cardiogenic Shock Registry Mannheim (CARESMA)

U

Universitätsmedizin Mannheim

Status

Enrolling

Conditions

Cardiogenic Shock

Study type

Observational

Funder types

Other

Identifiers

NCT05575856
2019-695N

Details and patient eligibility

About

The study aims to investigate clinically and prognostically relevant parameters in patients with cardiogenic shock within a monocentric observational clinical register.

Full description

All consecutive patients with a confirmed cardiogenic shock presenting at the internal intensive care Unit (ICU) at the University of Mannheim are included in the register and followed up during ICU stay and after that. Data of patients' admission status, cause of cardiogenic shock, baseline parameters and comorbidities are collected. Extensive information about echocardiography, electrocardiography and imaging procedures are included in the register. Laboratory values, microbiological investigations, organ dysfunction and organ replacement therapies, medication, adverse events, and complications were recorded for several days during the ICU stay (days 1, 2, 3, 5, 7, and 8). Standard scores for critically ill patients were calculated for the day of admission at the ICU if available, and several time points during the ICU stay. The register includes information about the mortality during ICU stay, 30-day mortality, 6-month mortality and 1-year mortality.

Enrollment

350 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Cardiogenic shock according to current guidelines

Exclusion criteria

  • other forms of shock not primary associated with cardiac dysfunction

Trial contacts and locations

1

Loading...

Central trial contact

Michael Behnes, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems